Novartis anticipates additional temporary stock shortage of Estradot (estradiol hemihydrate) 75 micrograms/24 hours, transdermal patch

Temporary stock shortage of this strength patch of around four weeks was first announced in January because of a printing issue, which was subsequently resolved. Now delays are anticipated from April 9, with supplies returning to normal levels within eight weeks.

PharmaTimes